Apoptosis in alcoholic and nonalcoholic steatohepatitis

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 3, 2005, Pages 3093-3099

  Feldstein, Ariel E ^a   Gores, Gregory J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Mayo Clinic   (United States)

Author keywords

Alcohol; Apoptosis; Bax; Fatty Acid; Hepatocyte; Lipoapoptosis; Liver; Review

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ALCOHOLIC FATTY LIVER; APOPTOSIS; CELL DEATH; CHRONIC LIVER DISEASE; HUMAN; LIVER; LIVER CELL; LIVER CIRRHOSIS; MITOCHONDRION; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TISSUE INJURY;

EID: 21344458172     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1765     Document Type: Review

References (71)

1. Arteel G, Marsano L, Mendez C, Bentley F, McClain CJ: Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol 17, 625-647 (2003)
2. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 346, 1221-1231 (2002)
3. Diehl AM: Alcoholic liver disease: natural history. Liver Transpl Surg 3, 206-211 (1997)
4. Caldwell SH, Crespo DM: The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 40, 578-584 (2004)
5. Brunt EM: Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6, 399-420, vii (2002)
6. Diehl AM: Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. Alcohol Clin Exp Res 25, 8S-14S (2001)
7. Arteel GE: Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124, 778-790 (2003)
8. Clark JM, Brancati FL, Diehl AM: Nonalcoholic fatty liver disease. Gastroenterology 122, 1649-1657 (2002)
9. Yuan J, Horvitz HR: A first insight into the molecular mechanisms of apoptosis. Cell 116, S53-56, 51 p following S59 (2004)
10. Delhalle S, Duvoix A, Schnekenburger M, Morceau F, Dicato M, Diederich M: An introduction to the molecular mechanisms of apoptosis. Ann N Y Acad Sci 1010, 1-8 (2003)
11. Riedl SJ, Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5, 897-907 (2004)
12. Guicciardi ME, Leist M, Gores GJ: Lysosomes in cell death. Oncogene 23, 2881-2890 (2004)
13. Szegezdi E, Fitzgerald U, Samali A: Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann N Y Acad Sci 1010, 186-194 (2003)
14. Rust C, Gores GJ: Apoptosis and liver disease. Am J Med 108, 567-574 (2000)
15. Guicciardi ME, Gores GJ: Cheating death in the liver. Nat Med 10, 587-588 (2004)
16. Antonsson B: Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem 256-257, 141-155 (2004)
17. Patel T, Steer CJ, Gores GJ: Apoptosis and the liver: A mechanism of disease, growth regulation, and carcinogenesis. Hepatology 30, 811-815 (1999)
18. Miyoshi H, Gores GJ: Apoptosis and the liver: relevance for the hepato-biliary-pancreatic surgeon. J Hepatobiliary Pancreat Surg 5, 409-415 (1998)
19. Feldstein AE, Gores GJ: An apoptosis biomarker goes to the HCV clinic. Hepatology 40, 1044-1046 (2004)
20. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ: Mechanisms of hepatotoxicity. Toxicol Sci 65, 166-176 (2002)
21. Higuchi H, Gores GJ: Mechanisms of liver injury: an overview. Curr Mol Med 3, 483-490 (2003)
22. Canbay A, Friedman S, Gores GJ: Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39, 273-278 (2004)
23. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ: Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 112, 152-159 (2003)
24. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ: Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123, 1323-1330 (2002)
25. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ: Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83, 655-663 (2003)
26. Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE: Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 39, 1230-1238 (2004)
27. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ: Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125, 437-443 (2003)
28. Fernandez-Checa JC: Alcoholic liver disease. Methods Find Exp Clin Pharmacol 18 Suppl B, 27-31 (1996)
29. Menon KV, Gores GJ, Shah VH: Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc 76, 1021-1029 (2001)
30. Brunt EM, Tiniakos DG: Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 16, 691-707 (2002)
31. Nanji AA: Apoptosis and alcoholic liver disease. Semin Liver Dis 18, 187-190 (1998)
32. Farinati F, Cardin R, Fiorentino M: Apoptosis in alcoholic hepatitis. J Hepatol 36, 570-571 (2002)
33. Day CP: Apoptosis in alcoholic hepatitis: a novel therapeutic target? J Hepatol 34, 330-333 (2001)
34. Zhao M, Laissue JA, Zimmermann A: TUNEL-positive hepatocytes in alcoholic liver disease. A retrospective biopsy study using DNA nick end-labelling. Virchows Arch 431, 337-344 (1997)
35. Kawahara H, Matsuda Y, Takase S: Is apoptosis involved in alcoholic hepatitis? Alcohol Alcohol 29 Suppl 1, 113-118 (1994)
36. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ: Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 34, 248-253 (2001)
37. Ziol M, Tepper M, Lohez M, Arcangeli G, Ganne N, Christidis C, Trinchet JC, Beaugrand M, Guillet JG, Guettier C: Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 34, 254-260 (2001)
38. Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, Baptista A, Moura MC, Camilo ME, Rodrigues CM: Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 99, 1708-1717 (2004)
39. Thurman RG, Bradford BU, Iimuro Y, Frankenberg MV, Knecht KT, Connor HD, Adachi Y, Wall C, Arteel GE, Raleigh JA, Forman DT, Mason RP: Mechanisms of alcohol-induced hepatotoxicity: studies in rats. Front Biosci 4, e42-46 (1999)
40. Castilla R, Gonzalez R, Fouad D, Fraga E, Muntane J: Dual effect of ethanol on cell death in primary culture of human and rat hepatocytes. Alcohol Alcohol 39, 290-296 (2004)
41. Browning JD, Horton JD: Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114, 147-152 (2004)
42. Kurose I, Higuchi H, Kato S, Miura S, Watanabe N, Kamegaya Y, Tomita K, Takaishi M, Horie Y, Fukuda M, Mizukami K, Ishii H: Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol. Gastroenterology 112, 1331-1343 (1997)
43. Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, Hokari R, Hirokawa M, Takaishi M, Zeki S, Nakamura T, Ebinuma H, Kato S, Ishii H: Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 25, 368-378 (1997)
44. Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W, Krammer PH, Galle PR: Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 212, 28191-28193 (1997)
45. Adachi M, Higuchi H, Miura S, Azuma T, Inokuchi S, Saito H, Kato S, Ishii H: Bax interacts with the voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am J Physiol Gastrointest Liver Physiol 287, G695-705 (2004)
46. Jaeschke H, Lemasters JJ: Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125, 1246-1257 (2003)
47. Chen Q, Galleano M, Cederbaum AI: Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem 272, 14532-14541 (1997)
48. Taieb J, Mathurin P, Poynard T, Gougerot-Pocidalo MA, Chollet-Martin S: Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet 351, 1930-1931 (1998)
49. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13, 267-276 (1991)
50. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL: Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14, 255-259 (1990)
51. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182, 1223-1230 (1995)
52. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG: Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26, 1530-1537 (1997)
53. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG: Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117, 942-952 (1999)
54. Pastorino JG, Hoek JB: Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 31, 1141-1152 (2000)
55. Pastorino JG, Shulga N, Hoek JB: TNF-alpha-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8. Am J Physiol Gastrointest Liver Physiol 285, G503-516 (2003)
56. Rodriguez DA, Moncada C, Nunez MT, Lavandero S, Ponnappa BC, Israel Y: Ethanol increases tumor necrosis factor-alpha receptor-1 (TNF-R1) levels in hepatic, intestinal, and cardiac cells. Alcohol 33, 9-15 (2004)
57. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413-1419 (1999)
58. Harrison SA, Neuschwander-Tetri BA: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 8, 861-879, ix (2004)
59. Day C, Saksena S: Non-alcoholic steatohepatitis: Definitions and pathogenesis. J Gastroenterol Hepatol 17 Suppl 3, S377-S384 (2002)
60. Day CP, James OF: Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845 (1998)
61. Choudhury J, Sanyal AJ: Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis 8, 575-594, ix (2004)
62. Diehl AM, Clarke J, Brancati F: Insulin resistance syndrome and nonalcoholic fatty liver disease. Endocr Pract 9 Suppl 2, 93-96 (2003)
63. Feldstein A, Gores GJ: Steatohepatitis and apoptosis: therapeutic implications. Am J Gastroenterol 99, 1718-1719 (2004)
64. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ: Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 39, 978-983 (2003)
65. Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, Lee FY, Diehl AM: Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29, 1131-1138 (1999)
66. Nanji AA: Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 8, 559-574, ix (2004)
67. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37, 56-62 (2002)
68. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ: Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40, 185-194 (2004)
69. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F: Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34, 1158-1163 (2001)
70. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J: Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40, 46-54 (2004)
71. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM: Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37, 343-350 (2003)